Quote | Super Quote
Future News

15/10/2026 13:01

INNOVENT BIO (01801): 565k shares, or HK$50.1m

  [ET Net News Agency, 15 October 2026]  A direct manual trade of 565,110 shares of INNOVENT BIO (01801) was registered at 1:00p.m.
  The deal amounted to HK$50.1m, or at HK$88.662 per share, 0.6% higher than previous close.
  INNOVENT BIO is now trading down 0.4% to HK$87.75, with 5.4 million shares of HK$478.52m changing hands. (rw)

Back to Future News

Previous︰15/10/2026 13:10  {Block Trade}VP DIV LO VOL: 3.1m shares, or HK$49.84m

Next︰15/10/2026 12:49  《午市前瞻》Hang Seng Index loses support at 24,000; Lenovo plunges but remains attractive in medium to long term

Other Future News
More

15/10/2026 13:42  Taiwan Stock MarketTaiwan stock market closes down 3.41%, at 46969.87 points

15/10/2026 13:35  【ＡＩ】Huang: If customers develop AI software unsafely, NVIDIA will stop supplying chips

15/10/2026 13:34  A-Share FocusShanghai Composite Index falls 2.37% in afternoon, Shenzhen Index and ChiNext both drop over 3%

15/10/2026 12:38  {Short Sales}Half-day T/O at HK$22bn, or 19% of Total

15/10/2026 12:07  Global market turmoil sends Hang Seng Index down 358 points, losing 24,000 level; Alibaba drops 5%, contributing nearly 100 points decline, Lenovo plunges nearly 14%

A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.